Reema Hasan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Reema Hasan has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
Hamid Ghanbari
Division of Cardiac Electrophysiology and Cardiology, Providence Hospital and Medical Center, Wayne State University, Southfield, Michigan
2 shared publicationsCarlos Duarte
Centro de Cardiology Nacional, Manágua, Nicaragua
1 shared publication- Christian Machado
Ascension Providence Hospital Southfield MI
1 shared publication Daniel Menesses
Centro de Cardiology Nacional, Manágua, Nicaragua
1 shared publicationDaniel Rivas
Centro de Cardiology Nacional, Manágua, Nicaragua
1 shared publicationDustin Feldman
Division of Cardiac Electrophysiology and Cardiology, Providence Hospital and Medical Center, Wayne State University, Southfield, Michigan
1 shared publication
Latest Publications
- 21 March 2011
- Published by Wiley in Pacing and Clinical Electrophysiology
- Vol. 34 (6) , 653-658
Safety, Efficacy, and Performance of Implanted Recycled Cardiac Rhythm Management (CRM) Devices in Underprivileged Patients
Patients in underdeveloped nations have limited access to life-saving medical technology including cardiac rhythm management (CRM) devices. We evaluated alternative means to provide such technology to this patient population while assessing the safety and efficacy of such a practice. Patients in the United States with clinical indications for extraction of CRM devices were consented. Antemortem CRM devices were cleaned and sterilized following a protocol established at our institution. Surveillance in vitro cultures were performed for quality assurance. The functional status of pulse generators was tested with a pacing system analyzer to confirm at least 70% battery life. Most generators were transported, in person, to an implanting institution in Nicaragua. Recipients with a Class I indication for CRM implantation, and meeting economical criteria set forth, were consented for implantation of a recycled device. Between 2003 and 2009, implantation was performed in 17 patients with an average age of 42.1 ± 20.3 years. Of the 17 patients, nine were male and eight were female. Mean follow-up was 68 ± 38 months. Device evaluation occurred prior to discharge, 4 weeks post implantation, and every 6 months thereafter. There were three deaths during the follow-up period secondary to myocardial infarction, stroke, and heart failure. Hematoma formation occurred in one patient. No infections, early battery depletion, or device malfunction were identified during follow-up. Our case series is the longest follow-up of recipients of recycled antemortem CRM devices. Our findings support the feasibility and safety of this alternative acquisition of life-saving technology.
- 21 March 2011
- Published by Wiley in Pacing and Clinical Electrophysiology
- Vol. 34 (6) , 653-658
Safety, Efficacy, and Performance of Implanted Recycled Cardiac Rhythm Management (CRM) Devices in Underprivileged Patients
Patients in underdeveloped nations have limited access to life-saving medical technology including cardiac rhythm management (CRM) devices. We evaluated alternative means to provide such technology to this patient population while assessing the safety and efficacy of such a practice. Patients in the United States with clinical indications for extraction of CRM devices were consented. Antemortem CRM devices were cleaned and sterilized following a protocol established at our institution. Surveillance in vitro cultures were performed for quality assurance. The functional status of pulse generators was tested with a pacing system analyzer to confirm at least 70% battery life. Most generators were transported, in person, to an implanting institution in Nicaragua. Recipients with a Class I indication for CRM implantation, and meeting economical criteria set forth, were consented for implantation of a recycled device. Between 2003 and 2009, implantation was performed in 17 patients with an average age of 42.1 ± 20.3 years. Of the 17 patients, nine were male and eight were female. Mean follow-up was 68 ± 38 months. Device evaluation occurred prior to discharge, 4 weeks post implantation, and every 6 months thereafter. There were three deaths during the follow-up period secondary to myocardial infarction, stroke, and heart failure. Hematoma formation occurred in one patient. No infections, early battery depletion, or device malfunction were identified during follow-up. Our case series is the longest follow-up of recipients of recycled antemortem CRM devices. Our findings support the feasibility and safety of this alternative acquisition of life-saving technology.
- 1 January 2010
- Published by Taylor & Francis in Future Cardiology
- Vol. 6 (1) , 113-127
Imaging modalities in cardiac electrophysiology
Cardiac imaging, both noninvasive and invasive, has become a crucial part of evaluating patients during the electrophysiology procedure experience. These anatomical data allow electrophysiologists to not only assess who is an appropriate candidate for each procedure, but also to determine the rate of success from these procedures. This article incorporates a review of the various cardiac imaging techniques available today, with a focus on atrial arrhythmias, ventricular arrhythmias and device therapy.
- 1 January 2010
- Published by Taylor & Francis in Future Cardiology
- Vol. 6 (1) , 113-127
Imaging modalities in cardiac electrophysiology
Cardiac imaging, both noninvasive and invasive, has become a crucial part of evaluating patients during the electrophysiology procedure experience. These anatomical data allow electrophysiologists to not only assess who is an appropriate candidate for each procedure, but also to determine the rate of success from these procedures. This article incorporates a review of the various cardiac imaging techniques available today, with a focus on atrial arrhythmias, ventricular arrhythmias and device therapy.